Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 -129.05M
March 31, 2026 -182.67M
December 31, 2025 -111.45M
September 30, 2025 -75.84M
June 30, 2025 -299.11M
March 31, 2025 131.38M
December 31, 2024 -104.12M
September 30, 2024 -14.97M
June 30, 2024 -10.38M
March 31, 2024 -46.58M
December 31, 2023 320.62M
September 30, 2023 -80.86M
June 30, 2023 52.22M
March 31, 2023 10.99M
December 31, 2022 -60.48M
September 30, 2022 -63.11M
June 30, 2022 27.13M
March 31, 2022 -13.89M
December 31, 2021 -243.80M
September 30, 2021 -6.885M
June 30, 2021 -0.143M
March 31, 2021 -125.11M
December 31, 2020 -119.09M
September 30, 2020 7.661M
June 30, 2020 -3.299M
Date Value
March 31, 2020 -2.592M
December 31, 2019 -36.04M
September 30, 2019 -13.67M
June 30, 2019 -36.74M
March 31, 2019 -53.84M
December 31, 2018 -52.62M
September 30, 2018 -28.86M
June 30, 2018 -55.43M
March 31, 2018 -56.11M
December 31, 2017 -16.31M
September 30, 2017 -36.21M
June 30, 2017 -47.83M
March 31, 2017 -10.93M
December 31, 2016 -6.408M
September 30, 2016 -46.21M
June 30, 2016 -10.81M
March 31, 2016 -36.12M
December 31, 2015 -35.41M
September 30, 2015 -22.84M
June 30, 2015 -48.52M
March 31, 2015 -43.78M
December 31, 2014 -91.43M
September 30, 2014 -3.774M
June 30, 2014 16.18M
March 31, 2014 -20.98M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Abbott Laboratories -673.00M
Merit Medical Systems, Inc. -110.13M
Teleflex, Inc. -15.51M
The Cooper Cos., Inc. -69.80M
Intuitive Surgical, Inc. -26.60M